Polymorphisms in NRGN are associated with schizophrenia, major depressive disorder and bipolar disorder in the Han Chinese population.

Wen Z, Chen J, Khan RAW, Wang M, Song Z, Li Z, et al. Polymorphisms in NRGN are associated with schizophrenia, major depressive disorder and bipolar disorder in the Han Chinese population. J Affect Disord. 2016;194:180-7. DOI: 10.1016/j.jad.2016.01.034. PubMed PMID: 26828755.

Management of psychotropic drugs during pregnancy.

Chisolm MS, Payne JL. Management of psychotropic drugs during pregnancy. BMJ. 2016;532:h5918. DOI: 10.1136/bmj.h5918. PubMed PMID: 26791406.

Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression and anxiety disorder.

Koivumaa-Honkanen HT, Honkanen R, Antikainen R, Hintikka J, Viinamäki H. Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression and anxiety disorder. Acta Psychiatr Scand. 1999;99(5):377-84. PubMed PMID: 10353454.

Correlates of life satisfaction among psychiatric patients.

Koivumaa-Honkanen HT, Viinamäki H, Honkanen R, Tanskanen A, Antikainen R, Niskanen L, et al.. Correlates of life satisfaction among psychiatric patients. Acta Psychiatr Scand. 1996;94(5):372-8. PubMed PMID: 9124086.

Schizophrenia.

Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388(10039):86-97. DOI: 10.1016/S0140-6736(15)01121-6. PubMed PMID: 26777917.

Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution--Authors' reply.

Perez J, Jones PB. Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution--Authors' reply. Lancet Psychiatry. 2016;3(1):18-9. DOI: 10.1016/S2215-0366(15)00537-4. PubMed PMID: 26772060.

Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution.

Fusar-Poli P, Schultze-Lutter F, Addington J. Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution. Lancet Psychiatry. 2016;3(1):18. DOI: 10.1016/S2215-0366(15)00491-5. PubMed PMID: 26772061.

Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study.

Zhang XY, Fan F-M, Chen D-C, Tan Y-L, Tan S-P, Hu K, et al. Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study. J Clin Psychiatry. 2016;77(2):205-11. DOI: 10.4088/JCP.14m09374. PubMed PMID: 26761708.

Vitamin supplementation in the treatment of schizophrenia.

Brown HE, Roffman JL. Vitamin supplementation in the treatment of schizophrenia. CNS Drugs. 2014;28(7):611-22. DOI: 10.1007/s40263-014-0172-4. PubMed PMID: 24846474; PubMed Central PMCID: PMC4083629.

Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia.

Roffman JL, Lamberti JS, Achtyes E, Macklin EA, Galendez GC, Raeke LH, et al. Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia. Jama Psychiatry. 2013;70(5):481-9. DOI: 10.1001/jamapsychiatry.2013.900. PubMed PMID: 23467813; PubMed Central PMCID: PMC4394629.